Skip to content
10-Q

Quarterly Report

Kezar Life Sciences, Inc.

0001628280-25-051623

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 7.32M sh
Shares Diluted Q3 2025 · Sep 30, 2025 7.32M sh
Shares Diluted Q3 2025 · Sep 30, 2025 7.31M sh
Shares Diluted Q3 2025 · Sep 30, 2024 7.3M sh
Shares Diluted Q3 2025 · Sep 30, 2024 7.29M sh
Dividends Paid Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2025 $8K
Capex Q3 2025 · Sep 30, 2024 $18K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$39.82M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$57.39M
Long Term Debt Q3 2025 · Sep 30, 2025 $1.37M
Long Term Debt Q3 2025 · Dec 31, 2024 $5.11M
Short Term Debt Q3 2025 · Sep 30, 2025 $5.28M
Short Term Debt Q3 2025 · Dec 31, 2024 $5.22M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $38.94M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $41.75M
Stockholders Equity Q3 2025 · Sep 30, 2025 $82.98M
Stockholders Equity Q3 2025 · Jun 30, 2025 $91.79M
Stockholders Equity Q3 2025 · Mar 31, 2025 $103.07M
Stockholders Equity Q3 2025 · Dec 31, 2024 $116.92M
Stockholders Equity Q3 2025 · Sep 30, 2024 $134.05M
Stockholders Equity Q3 2025 · Jun 30, 2024 $150.69M
Stockholders Equity Q3 2025 · Mar 31, 2024 $169.12M
Stockholders Equity Q3 2025 · Dec 31, 2023 $187.57M
Current Liabilities Q3 2025 · Sep 30, 2025 $13.38M
Current Liabilities Q3 2025 · Dec 31, 2024 $20.33M
Total Liabilities Q3 2025 · Sep 30, 2025 $14.75M
Total Liabilities Q3 2025 · Dec 31, 2024 $27.77M
Current Assets Q3 2025 · Sep 30, 2025 $94.5M
Current Assets Q3 2025 · Dec 31, 2024 $137.49M
Total Assets Q3 2025 · Sep 30, 2025 $97.73M
Total Assets Q3 2025 · Dec 31, 2024 $144.68M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.53
Eps Diluted Q3 2025 · Sep 30, 2025 −$5.67
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.78
Eps Diluted Q3 2025 · Sep 30, 2024 −$8.72
Eps Basic Q3 2025 · Sep 30, 2025 −$1.53
Eps Basic Q3 2025 · Sep 30, 2025 −$5.67
Eps Basic Q3 2025 · Sep 30, 2024 −$2.78
Eps Basic Q3 2025 · Sep 30, 2024 −$8.72
Sga Expense Q3 2025 · Sep 30, 2025 $4.8M
Sga Expense Q3 2025 · Sep 30, 2025 $15.27M
Sga Expense Q3 2025 · Sep 30, 2024 $5.71M
Sga Expense Q3 2025 · Sep 30, 2024 $17.85M
Rd Expense Q3 2025 · Sep 30, 2025 $6.91M
Rd Expense Q3 2025 · Sep 30, 2025 $28.68M
Rd Expense Q3 2025 · Sep 30, 2024 $16.24M
Rd Expense Q3 2025 · Sep 30, 2024 $49.71M
Net Income Q3 2025 · Sep 30, 2025 −$11.23M
Net Income Q3 2025 · Sep 30, 2025 −$41.49M
Net Income Q3 2025 · Jun 30, 2025 −$13.7M
Net Income Q3 2025 · Mar 31, 2025 −$16.56M
Net Income Q3 2025 · Sep 30, 2024 −$20.31M
Net Income Q3 2025 · Sep 30, 2024 −$63.52M
Net Income Q3 2025 · Jun 30, 2024 −$21.55M
Net Income Q3 2025 · Mar 31, 2024 −$21.66M
Operating Income Q3 2025 · Sep 30, 2025 −$11.72M
Operating Income Q3 2025 · Sep 30, 2025 −$43.94M
Operating Income Q3 2025 · Sep 30, 2024 −$21.95M
Operating Income Q3 2025 · Sep 30, 2024 −$69.04M